{"id":"https://openalex.org/W4200192156","doi":"https://doi.org/10.1093/ofid/ofab466.1049","title":"854. Long-term Outcomes of Participants on F/TAF for Pre-Exposure Prophylaxis: Results for 144 Weeks of Follow-Up in the DISCOVER Trial","display_name":"854. Long-term Outcomes of Participants on F/TAF for Pre-Exposure Prophylaxis: Results for 144 Weeks of Follow-Up in the DISCOVER Trial","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W4200192156","doi":"https://doi.org/10.1093/ofid/ofab466.1049"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofab466.1049","doi":"https://doi.org/10.1093/ofid/ofab466.1049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1049","pdf_url":"https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S517/41526197/ofab466.1049.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S517/41526197/ofab466.1049.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069170911","display_name":"Moti N. Ramgopal","orcid":"https://orcid.org/0000-0001-7448-1976","observed_orcids":["https://orcid.org/0000-0001-7448-1976"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moti Ramgopal","raw_affiliation_strings":["Midway Research Center, Ft. Pierce, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midway Research Center, Ft. Pierce, FL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089993955","display_name":"Peter Jerome Ruane","orcid":"https://orcid.org/0000-0002-7170-9928","observed_orcids":["https://orcid.org/0000-0002-7170-9928"]},"institutions":[{"id":"https://openalex.org/I4210148755","display_name":"Ruane Medical","ror":"https://ror.org/05prbcv50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210148755"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter Ruane","raw_affiliation_strings":["Ruane Medical & Liver Health Institute, Los Angeles, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ruane Medical & Liver Health Institute, Los Angeles, CA","institution_ids":["https://openalex.org/I4210148755"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003994482","display_name":"Yongwu Shao","orcid":"https://orcid.org/0009-0009-5384-5131","observed_orcids":["https://orcid.org/0009-0009-5384-5131"]},"institutions":[{"id":"https://openalex.org/I4210140816","display_name":"Gilead Sciences (United States)","ror":"https://ror.org/056546b03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140816"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yongwu Shao","raw_affiliation_strings":["Gilead Sciences Inc, Foster City, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gilead Sciences Inc, Foster City, CA","institution_ids":["https://openalex.org/I4210140816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011617429","display_name":"Ramin Ebrahimi","orcid":"https://orcid.org/0000-0003-3728-1339","observed_orcids":["https://orcid.org/0000-0003-3728-1339","https://orcid.org/0000-0002-1412-4392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ramin Ebrahimi","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020872099","display_name":"Alex Kintu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alex Kintu","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073519594","display_name":"Christoph C Carter","orcid":"https://orcid.org/0000-0001-7793-8011","observed_orcids":["https://orcid.org/0000-0001-7793-8011"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christoph C Carter","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076529428","display_name":"Moupali Das","orcid":"https://orcid.org/0000-0001-5034-8185","observed_orcids":["https://orcid.org/0000-0001-5034-8185"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Moupali Das","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064486492","display_name":"Jared M. Baeten","orcid":"https://orcid.org/0000-0001-8242-8438","observed_orcids":["https://orcid.org/0000-0001-8242-8438"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jared Baeten","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110434587","display_name":"Cynthia C Brinson","orcid":"https://orcid.org/0000-0002-3024-2815","observed_orcids":["https://orcid.org/0000-0002-3024-2815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia Brinson","raw_affiliation_strings":["Central Texas Clinical Research, Austin, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Texas Clinical Research, Austin, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064101905","display_name":"Peter Shalit","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Shalit","raw_affiliation_strings":["Midway Research Center, Ft. Pierce, FL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Midway Research Center, Ft. Pierce, FL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013318234","display_name":"Karam Mounzer","orcid":"https://orcid.org/0000-0001-8537-7103","observed_orcids":["https://orcid.org/0000-0001-8537-7103"]},"institutions":[{"id":"https://openalex.org/I860670893","display_name":"Philadelphia Fight","ror":"https://ror.org/00np1gf38","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I860670893"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karam Mounzer","raw_affiliation_strings":["Philadelphia FIGHT, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philadelphia FIGHT, Philadelphia, PA","institution_ids":["https://openalex.org/I860670893"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3465,"currency":"USD","value_usd":3465},"apc_paid":{"value":3465,"currency":"USD","value_usd":3465},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22703533,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"Supplement_1","first_page":"S517","last_page":"S518"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.6797000169754028,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.6797000169754028,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.3156999945640564,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9589999914169312},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9359999895095825},{"id":"https://openalex.org/keywords/hiv-pre-exposure-prophylaxis","display_name":"HIV pre-exposure prophylaxis","score":0.949999988079071},{"id":"https://openalex.org/keywords/hiv-incidence","display_name":"HIV incidence","score":0.7089999914169312},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.8510000109672546},{"id":"https://openalex.org/keywords/glomerular-filtration","display_name":"glomerular filtration","score":0.8209999799728394},{"id":"https://openalex.org/keywords/renal-safety","display_name":"renal safety","score":0.7149999737739563},{"id":"https://openalex.org/keywords/open-label-extension","display_name":"open-label extension","score":0.8159999847412109},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5400000214576721},{"id":"https://openalex.org/keywords/tenofovir-diphosphate","display_name":"tenofovir diphosphate","score":0.781000018119812},{"id":"https://openalex.org/keywords/genotypic-resistance-testing","display_name":"genotypic resistance testing","score":0.6349999904632568},{"id":"https://openalex.org/keywords/long-term-outcomes","display_name":"long-term outcomes","score":0.7649999856948853},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.30300000309944153},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.5429999828338623}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8930878043174744},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6240565776824951},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.6100367903709412},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5647509694099426},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.5619919896125793},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.44114112854003906},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.42209213972091675},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.4218178987503052},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.17109069228172302},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14913266897201538},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1093/ofid/ofab466.1049","doi":"https://doi.org/10.1093/ofid/ofab466.1049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1049","pdf_url":"https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S517/41526197/ofab466.1049.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofab466.1049","doi":"https://doi.org/10.1093/ofid/ofab466.1049","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofab466.1049","pdf_url":"https://academic.oup.com/ofid/article-pdf/8/Supplement_1/S517/41526197/ofab466.1049.pdf","source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320312382","display_name":"ViiV Healthcare","ror":"https://ror.org/01cc9yk21"},{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"},{"id":"https://openalex.org/F4320332585","display_name":"Allergan","ror":"https://ror.org/00wthd003"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4200192156.pdf","grobid_xml":"https://content.openalex.org/works/W4200192156.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2981939849","https://openalex.org/W3119031068","https://openalex.org/W2982203495","https://openalex.org/W3120565555","https://openalex.org/W3175868284","https://openalex.org/W4400453780","https://openalex.org/W2694610825","https://openalex.org/W2116531236","https://openalex.org/W3172555725","https://openalex.org/W2553949721"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"In":[2],"DISCOVER,":[3],"a":[4,157,279,296,331,363],"multinational":[5],"randomized":[6,65,83,137],"controlled":[7],"trial,":[8],"F/TAF":[9,67,70,90,107,139,170,248,293,337,361],"demonstrated":[10],"noninferior":[11],"efficacy":[12],"compared":[13],"to":[14,66,88,128,138,156,268,287],"F/TDF":[15],"for":[16,61,91,208,330,338,368],"HIV":[17,102,172,217,340],"prevention":[18],"with":[19,197,278,344],"improved":[20],"bone":[21,117,315],"mineral":[22,118,316],"density":[23,119,317],"and":[24,39,45,68,110,115,121,145,177,237,258,313,318,346,365],"renal":[25,347],"safety":[26],"biomarkers":[27],"at":[28,46,92,225],"the":[29,50,53,72,82,97,133,142,174,180,188,209,226,292],"primary":[30,227],"endpoint":[31],"(when":[32],"all":[33],"participants":[34,62,79,105,135,168,214],"had":[35,41,249],"reached":[36,42],"48":[37,94],"weeks":[38,95,236,354],"50%":[40],"96":[43,235],"weeks)":[44],"week":[47,288],"(W)":[48],"96,":[49],"end":[51],"of":[52,132,159,163,282,305,327,336,355],"blinded":[54,84,175],"phase.":[55,76,99,182],"We":[56,100],"now":[57],"report":[58],"W144":[59,109,269],"outcomes":[60],"who":[63,80,373],"were":[64,147],"continued":[69],"in":[71,96,104,113,122,173,179,251,259,291,311,319,371],"open-label":[73],"extension":[74],"(OLE)":[75],"Methods":[77],"All":[78],"completed":[81],"phase":[85,176],"could":[86],"opt":[87],"receive":[89],"least":[93],"OLE":[98,143,181,326],"evaluated":[101],"incidence":[103,218,341],"on":[106,149,165,187],"through":[108,152,234,243,321,352],"assessed":[111],"changes":[112],"hip":[114,252,312],"spine":[116,260,314],"(BMD)":[120],"glomerular":[123],"function":[124,348],"(eGFR)":[125],"from":[126,266,285,376],"baseline":[127,267,286],"W144.":[129],"Results":[130],"2,080":[131],"2,694":[134],"initially":[136],"opted":[140],"into":[141],"phase,":[144],"1,933":[146],"still":[148],"study":[150],"drug":[151],"W144,":[153],"thereby":[154],"leading":[155],"total":[158],"7,885":[160],"person-years":[161],"(PY)":[162],"follow-up":[164],"F/TAF.":[166],"Eight":[167],"taking":[169,215,247],"acquired":[171],"3":[178,189,210,303],"Dried":[183],"blood":[184],"spot":[185],"analyses":[186],"OL":[190],"infections":[191],"found":[192],"tenofovir":[193],"diphosphate":[194],"levels":[195],"consistent":[196],"low":[198,343],"adherence.":[199],"Genotypic":[200],"resistance":[201,206],"testing":[202],"showed":[203],"no":[204],"relevant":[205],"mutations":[207],"new":[211],"infections.":[212],"Among":[213],"F/TAF,":[216],"was":[219],"0.16/100":[220,229],"PY":[221,230,239],"(95%":[222,231,240],"CI":[223,232,241],"0.06-0.33)":[224],"endpoint,":[228],"0.07-0.31)":[233],"0.14/100":[238],"0.07-0.25)":[242],"144":[244,276,323,353],"weeks.":[245],"Participants":[246,290],"increases":[250],"BMD":[253,261,345],"(mean":[254,262],"percentage":[255,263],"change":[256,264],"+0.54%)":[257],"+1.02%)":[265],"(Figure":[270],"1).":[271],"Median":[272],"eGFR":[273,320],"increased":[274],"over":[275,302],"weeks,":[277],"median":[280,297],"increase":[281],"2.6":[283],"mL/min":[284],"144.":[289],"arm":[294],"gained":[295],"2.3":[298],"kg":[299],"(IQR":[300],"-0.9-5.8)":[301],"years":[304],"follow":[306],"up.":[307],"Figure":[308],"1.":[309],"Changes":[310],"Week":[322],"Conclusion":[324],"The":[325],"DISCOVER":[328],"allowed":[329],"long-term":[332,369],"assessment":[333],"(144":[334],"wks.)":[335],"PrEP.":[339,377],"remained":[342],"parameters":[349],"remaining":[350],"stable":[351],"follow-up.":[356],"These":[357],"findings":[358],"demonstrate":[359],"that":[360],"is":[362],"safe":[364],"effective":[366],"option":[367],"use":[370],"people":[372],"would":[374],"benefit":[375],"Disclosures":[378],"Moti":[379],"Ramgopal,":[380],"MD":[381],"FACP":[382],"FIDSA,":[383],"Abbvie":[384,509,558],"(Scientific":[385,510,514,520,533,538,543],"Research":[386,393,400,403,411,416,426,437,445,451,511,515,521,534,539,544,598,601,608],"Study":[387,394,401,412,417,512,516,522,535,540,545,599],"Investigator,":[388,395,402,418,523,546,600],"Speaker\u2019s":[389,396,407,419,442,529,552,565,574,578,605,612,618,622],"Bureau)Gilead":[390],"(Consultant,":[391,398,409,414,425,436,444,450,562,568,571,596,607,621],"Scientific":[392,399,410,415,597],"Bureau)Janssen":[397,606],"Grant":[404,427,431,438,446,452,602,609,615],"or":[405,428,432,439,447,453,525,548,590,603,610,616],"Support,":[406,440,564,573,577,604,611,617],"Bureau)Merck":[408,443,575,613],"Investigator)ViiV":[413,541],"Bureau)":[420,553,584,623],"Peter":[421,554],"Ruane,":[422],"MD,":[423,473,483,491,499,508,556,587],"AbbVie":[424],"Support)Allergan":[429],"(Research":[430,614],"Support)Gilead":[433,560],"Sciences":[434,459,467,476,485,493,502,518,561,594],"Inc.":[435,460,468,477,486,494,503,519,595],"Shareholder,":[441],"Support)ViiV":[448],"Healthcare":[449,542,582,620],"Support)":[454],"Yongwu":[455],"Shao,":[456],"PhD,":[457,557],"Gilead":[458,466,475,484,492,501],"(Employee,":[461,469,478,487,495,504],"Shareholder)":[462,470,479,488,496,505],"Ramin":[463],"Ebrahimi,":[464],"MSc,":[465],"Alex":[471],"Kintu,":[472],"ScD,":[474],"Christoph":[480],"C.":[481],"Carter,":[482],"Moupali":[489],"Das,":[490],"Jared":[497],"Baeten,":[498],"PHD,":[500],"Cynthia":[506],"Brinson,":[507],"Investigator)BI":[513],"Investigator)Gilead":[517],"Advisor":[524,547],"Review":[526,549,591],"Panel":[527,550,592],"member,":[528,551],"Bureau,":[530],"Personal":[531],"fees)GSK":[532],"Investigator)Novo":[536],"Nordisk":[537],"Shalit,":[555],"(Grant/Research":[559,576],"Grant/Research":[563,569,572],"Bureau)Glaxo":[566],"Smithkline":[567],"Support)Janssen":[570],"Bureau)Thera":[579],"(Speaker\u2019s":[580,583],"Bureau)ViiV":[581,619],"Karam":[585],"Mounzer,":[586],"Epividian":[588],"(Advisor":[589],"member)Gilead":[593]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2021-12-31T00:00:00"}